Premium Nahrungsergänzungsmittel | artgerecht

Thymosin Beta-4 – Effects, Uses and Research

Thymosin beta-4 is a naturally occurring peptide that plays a key role in tissue regeneration, wound healing, and the regulation of inflammation.

Regular tips about health Regular tips about health

Things worth knowing about "Thymosin Beta-4"

Thymosin beta-4 is a naturally occurring peptide that plays a key role in tissue regeneration, wound healing, and the regulation of inflammation.

What is Thymosin Beta-4?

Thymosin beta-4 (also referred to as Tβ4 or its synthetic analogue TB-500) is a small, biologically active peptide consisting of 43 amino acids, originally isolated from the thymus gland. It is found in virtually all human tissues and body fluids and is naturally produced by the body. Thymosin beta-4 is considered one of the most important tissue-regenerative peptides and is the subject of extensive biomedical research worldwide.

Biological Functions

Thymosin beta-4 performs a wide range of critical functions in the human body:

Actin binding and cytoskeletal regulation: Thymosin beta-4 binds G-actin (monomeric actin), thereby regulating the polymerization of the actin cytoskeleton, which is essential for cell migration and division.
Wound healing: The peptide promotes the migration of keratinocytes and endothelial cells into wound areas, accelerating the healing process.
Angiogenesis: Thymosin beta-4 stimulates the formation of new blood vessels (angiogenesis), which is critical for supplying regenerating tissue with nutrients and oxygen.
Anti-inflammatory activity: It reduces inflammation by inhibiting the release of pro-inflammatory cytokines, including suppression of NF-κB signaling pathways.
Cardioprotection: Studies have demonstrated that thymosin beta-4 can protect cardiac muscle cells following a myocardial infarction and support the regeneration of heart tissue.
Neuroprotection: Emerging evidence suggests that thymosin beta-4 may protect nerve cells and support recovery following neurological injuries.

Medical Applications

Thymosin beta-4 is being investigated in clinical and preclinical research for a range of indications:

Wound Healing and Dermatology

Clinical studies have indicated that thymosin beta-4, administered topically or systemically, can accelerate the healing of chronic wounds, burns, and corneal defects. Positive results have been particularly reported in patients with diabetic foot ulcers.

Cardiovascular Disease

In preclinical models, thymosin beta-4 improved the survival of cardiomyocytes following myocardial infarction and helped preserve cardiac function. Phase I and Phase II clinical trials have already been conducted in this area.

Ophthalmology

Thymosin beta-4 is being investigated as an active ingredient in eye drops for the treatment of corneal erosions and dry eye syndrome. A related investigational product (RGN-259) has undergone clinical evaluation.

Neurology

Experimental studies suggest that thymosin beta-4 may support remyelination of nerve fibers in diseases such as multiple sclerosis, although further clinical evidence is needed.

Thymosin Beta-4 in Sports and Doping

The synthetic analogue TB-500 has been misused in competitive sports due to its attributed regenerative and performance-enhancing properties. The World Anti-Doping Agency (WADA) has included thymosin beta-4 on its list of prohibited substances. Its use outside of controlled clinical trials is therefore banned in sport and carries health risks due to uncontrolled dosing and insufficiently studied long-term effects.

Safety and Tolerability

In clinical studies, thymosin beta-4 has generally demonstrated a favorable safety profile. Reported side effects include mild local reactions at the injection site, transient fatigue, and occasional headaches. Long-term human safety data remain limited. Its use should be restricted to clinical trial settings or supervised medical practice.

Current State of Research

Thymosin beta-4 is the subject of numerous ongoing clinical trials. RegeneRx Biopharmaceuticals has conducted multiple Phase I and Phase II studies. Research continues to focus on optimizing delivery methods, dosing strategies, and identifying additional therapeutic applications. Despite promising preclinical results, broad clinical approval has not yet been granted.

References

Goldstein AL, Hannappel E, Sosne G, Kleinman HK. Thymosin beta-4: a multi-functional regenerative peptide. Basic properties and clinical applications. Expert Opinion on Biological Therapy, 2012;12(1):37–51.
Sosne G, Qiu P, Goldstein AL, Wheater M. Biological activities of thymosin beta4 defined by active sites in short peptide sequences. FASEB Journal, 2010;24(7):2144–2151.
World Anti-Doping Agency (WADA). Prohibited List 2024. Available at: https://www.wada-ama.org

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.

Most read entries

3 Posts in this encyclopedia category